Literature DB >> 6401540

Monoamine oxidase inhibitors in depression.

P Rowan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6401540      PMCID： PMC1546337          DOI： 10.1136/bmj.286.6360.225-d

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  8 in total

1.  Comparison of antidepressant drugs in depressive illnesses.

Authors:  P J DALLY; P ROHDE
Journal:  Lancet       Date:  1961-01-07       Impact factor: 79.321

2.  Effects of iproniazid in depressive syndromes.

Authors:  E D WEST; P J DALLY
Journal:  Br Med J       Date:  1959-06-13

3.  A clinical and biochemical study of a trial of iproniazid in the treatment of depression.

Authors:  C M PARE; M SANDLER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-08       Impact factor: 10.154

4.  Drugs and group psychotherapy in neurotic depression.

Authors:  L Covi; R S Lipman; L R Derogatis; J E Smith; J H Pattison
Journal:  Am J Psychiatry       Date:  1974-02       Impact factor: 18.112

5.  A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms.

Authors:  D W Kay; R F Garside; T J Fahy
Journal:  Br J Psychiatry       Date:  1973-07       Impact factor: 9.319

6.  Interaction of drug therapy with marital therapy in depressive patients.

Authors:  A S Friedman
Journal:  Arch Gen Psychiatry       Date:  1975-05

7.  Phenelzine and amitriptyline: effects on symptoms of neurotic depression.

Authors:  P R Rowan; E S Paykel; R R Parker
Journal:  Br J Psychiatry       Date:  1982-05       Impact factor: 9.319

8.  Response to phenelzine and amitriptyline in subtypes of outpatient depression.

Authors:  E S Paykel; P R Rowan; R R Parker; A V Bhat
Journal:  Arch Gen Psychiatry       Date:  1982-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.